An interventional study of INSPiRe Programme in Suicide, sponsored by University of Manchester. Completed at 1 site in United Kingdom. Open to male participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2019-08-12.
Sponsored by University of Manchester · Not applicable, Interventional, and Treatment
This study aims to assess the acceptability and feasibility of a short-term, intensive Cognitive Behavioural Therapy (CBT) delivered to male prisoners who have thoughts of ending their lives.
10 hours of an adapted CBT therapy for suicide will be delivered across 2 weeks in 5 2 hour sessions to male prisoners. They will initially be assessed on several measures of mood, social support and suicidality. They will then undergo therapy. Following this they will be asked to re-completed the initial measures and a post-therapy interview to ascertain their thoughts on their experience of the therapy.
607 studies on the registry are indexed under Suicide; 162 are open to participants now.
This study's enrollment of 13 is below the median of 104 across 490 interventional studies indexed under Suicide.
Browse Suicide studies →University of Manchester is the lead sponsor of 201 studies on the registry; 44 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
10 hours of intensive CBT for suicide will be delivered to male prisoners who are having thoughts of ending their lives. This will be delivered in 2 hours sessions, 5 times across 2 weeks.
Other: INSPiRe Programme
Intensive CBT for suicide
The Client Satisfaction Questionnaire (CSQ-8)
A measure of participant satisfaction with therapy
Time frame: 20 minutes
Therapist Session Summary
Measuring levels of adherence and engagement
Time frame: 5 minutes
Discharge summary sheet
Capturing individuals' adherence to the programme or discharge from it
Time frame: 15 minutes
Therapist Rating Form
Giving an overall picture of each individual's engagement and progress during the study.
Time frame: 20 minutes
Post-intervention interview
Qualitative interview to explore the participant's experience of therapy
Time frame: 1 hour
Plan to share: No
No publications or documents are linked to this record.
Ran from Jun 2018 to primary completion in Apr 2019, 10 months.
Of 308 non-industry interventional studies with no phase under Suicide, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 54. This study's 10 months is below that.
Counting every sponsor, half of 319 studies reached it within 30 months; a quarter within 15 and three quarters within 53.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.